Your browser doesn't support javascript.
loading
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance.
Llorca-Cardenosa, Marta J; Aronson, Lauren I; Krastev, Dragomir B; Nieminuszczy, Jadwiga; Alexander, John; Song, Feifei; Dylewska, Malgorzata; Broderick, Ronan; Brough, Rachel; Zimmermann, Astrid; Zenke, Frank T; Gurel, Bora; Riisnaes, Ruth; Ferreira, Ana; Roumeliotis, Theodoros; Choudhary, Jyoti; Pettitt, Stephen J; de Bono, Johann; Cervantes, Andres; Haider, Syed; Niedzwiedz, Wojciech; Lord, Christopher J; Chong, Irene Y.
Afiliação
  • Llorca-Cardenosa MJ; The Institute of Cancer Research, London, United Kingdom.
  • Aronson LI; The Institute of Cancer Research, London, United Kingdom.
  • Krastev DB; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
  • Nieminuszczy J; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Alexander J; The Institute of Cancer Research, London, United Kingdom.
  • Song F; The Institute of Cancer Research, London, United Kingdom.
  • Dylewska M; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
  • Broderick R; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Brough R; The Institute of Cancer Research, London, United Kingdom.
  • Zimmermann A; The Institute of Cancer Research, London, United Kingdom.
  • Zenke FT; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
  • Gurel B; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Riisnaes R; The healthcare business of Merck KGaA, Biopharma R&D, Translational Innovation Platform Oncology, Darmstadt, Germany.
  • Ferreira A; The healthcare business of Merck KGaA, Biopharma R&D, Translational Innovation Platform Oncology, Darmstadt, Germany.
  • Roumeliotis T; The Institute of Cancer Research, London, United Kingdom.
  • Choudhary J; The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
  • Pettitt SJ; The Institute of Cancer Research, London, United Kingdom.
  • de Bono J; The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
  • Cervantes A; The Institute of Cancer Research, London, United Kingdom.
  • Haider S; The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
  • Niedzwiedz W; The Institute of Cancer Research, London, United Kingdom.
  • Lord CJ; The Institute of Cancer Research, London, United Kingdom.
  • Chong IY; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
Cancer Res ; 82(21): 3962-3973, 2022 11 02.
Article em En | MEDLINE | ID: mdl-36273494
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido